PTGS2 and non-small cell lung carcinoma: Similarly, Shimizu et al. [65] also showed that tumor-infiltrating FoxP3+ Tregs correlate with cyclooxygenase-2 (COX-2) expression and increased tumor recurrence in stage I to stage III NSCLC.